Aptose Announces Proposed Public Offering of Common Shares

Dec 16, 2019 4:19pm EST

Aptose Presents New Preclinical CG-806 Data at the 2019 ASH Annual Meeting

Dec 09, 2019 11:00am EST

Aptose Presents Highlights From Corporate Event At ASH

Dec 07, 2019 11:00am EST

Aptose Appoints Rafael Bejar, M.D., Ph.D., as Chief Medical Officer

Dec 04, 2019 7:30am EST

Aptose to Present at 31st Annual Piper Jaffray Healthcare Conference

Dec 02, 2019 7:30am EST

Aptose to Present at BIO-Europe Conference

Nov 07, 2019 7:30am EST

Aptose to Present New CG-806 Data at the 2019 ASH Annual Meeting

Nov 06, 2019 9:54am EST

Aptose Reports Results for the Third Quarter Ended September 30, 2019

Nov 05, 2019 4:02pm EST

Aptose To Release Third Quarter Ended September 30, 2019 Financial Results and Hold Conference Call on November 5, 2019

Oct 22, 2019 7:00am EDT

Aptose to Participate at 5th International Conference on Acute Myeloid Leukemia of the European School of Haematology (ESH)

Oct 10, 2019 7:30am EDT